NMTC - NeuroOne Medical Technologies Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 22.65M
Enterprise Value 18.30M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)91.95
Price/Book (mrq)2.86
Enterprise Value/Revenue 26.85
Enterprise Value/EBITDA -1.98

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 311.40%
S&P500 52-Week Change 31.77%
52 Week High 32.9500
52 Week Low 30.7800
50-Day Moving Average 31.4863
200-Day Moving Average 31.5707

Share Statistics

Avg Vol (3 month) 3228.42k
Avg Vol (10 day) 3153.07k
Shares Outstanding 517.56M
Implied Shares Outstanding 6N/A
Float 814.92M
% Held by Insiders 117.59%
% Held by Institutions 18.08%
Shares Short (May 14, 2023) 4111.65k
Short Ratio (May 14, 2023) 40.62
Short % of Float (May 14, 2023) 40.67%
Short % of Shares Outstanding (May 14, 2023) 40.64%
Shares Short (prior month Apr 13, 2023) 4395.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Mar 31, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -230.18%
Operating Margin (ttm)-231.46%

Management Effectiveness

Return on Assets (ttm)-55.43%
Return on Equity (ttm)-100.66%

Income Statement

Revenue (ttm)4.08M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)1,174.30%
Gross Profit (ttm)-3.05M
Net Income Avi to Common (ttm)-9.39M
Diluted EPS (ttm)-0.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.6M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)243.98k
Total Debt/Equity (mrq)4.41
Current Ratio (mrq)4.10
Book Value Per Share (mrq)0.33

Cash Flow Statement

Operating Cash Flow (ttm)-8.66M
Levered Free Cash Flow (ttm)-5.48M